alexa Use of Human Embryonic Stem Cells in the Treatment of Parkinsons Disease: A Case Report | OMICS International | Abstract
ISSN: 1522-4821

International Journal of Emergency Mental Health and Human Resilience
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Use of Human Embryonic Stem Cells in the Treatment of Parkinsons Disease: A Case Report

Geeta Shroff1*, Petra Hopf-Seidel2

1Director, Nutech Mediworld, New Delhi, India

2Neurologist and psychiatrist, expert for Lyme Disease, Ansbach, Germany

*Corresponding Author:
E-mail: [email protected]

Abstract

Parkinson’s disease (PD), a progressive disorder of the central nervous system, affects every 1 in 100 persons, aged around 70 in Europe. PD is characterized by abnormalities affecting both the motor system and the non-motor systems that include tremor, gait disorder, bradykinesia, depression, cognitive impairments, dysautonomia and sleep disturbances. Both surgical and drug treatments are available for the treatment of PD, but none has been able to halt the progression of the degenerative disease. We present the case of 65-year old male patient with PD who was treated with human embryonic stem cells (hESCs). The patient showed significant improvement in his health following the treatment; such as reduction in tremors, bradykinesia, muscle rigidity, pain and stiffness in the neck, shoulder and low back and improvement in the range of movements of the neck. The patient was able to balance himself while walking, had reduction in numbness in his left hand and both of his legs. He was able to speak louder and had improved writing skills. No adverse event or teratoma formation was observed. hESC therapy in our study showed beneficial effects in the patient with PD, but future clinical trials are needed to gather more evidence to support our findings.

Recommended Conferences

32nd World Psychiatrists and Psychologists Meet

Sydney, Australia

12th World Congress on Alzheimers Disease & Dementia

Budapest, Hungary
Share This Page
Top